Evaluation of Outcome and Performance of COVID-19 ICUs in Imam Reza General Hospital, Tabriz, Iran
-
Mojtaba Mohammadzadeh Lame
,
Samad EJ Golzari
,
Ata Mahmoodpoor
,
Asma Taghizadeh Anhari
,
Senobar Naderian
,
Nasrin Jafari
,
Maryam Soleimanpour
,
Robab Mehdizadeh Esfanjani
,
Masoud Faghieh Dinavari
,
Hassan Soleimanpour
Abstract
Background: The performance and outcomes of intensive care units play a critical role in determining the overall success of a healthcare system's response to the pandemic.
Methods: In this prospective study conducted between December 2021 and December 2023, data on the number of hospitalized patients, bed occupancy rate, average length of stay in the ICU, average number of admissions to the ICU, average APACHE scores of the patients on admission to the ICU, number of successful CPRs, number of deaths and discharges, and predicted mortality rate were extracted from a questionnaire completed for all COVID-19 ICUs of Imam Reza Hospital in Tabriz, Iran. Data were analyzed using SPSS ver22 software.
Results: In this study, a total of 3188 COVID-19 patients were hospitalized in the ICUs of Imam Reza Hospital during the specified period, with 2342 patients in 2021 and 846 patients in 2022. The average number of hospitalized patients per month in Imam Reza Educational Medical Center during the study period was 132.08. The average APACHE score of COVID patients on admission to the center's ICUs was on average 6.31 points higher than the global average (P < 0.001). In addition, the average predicted mortality rate in the center's COVID ICUs was approximately 1.08 lower than the reported global rate (P = 0.001).
Conclusion: The results of this study demonstrate the significant management capabilities of the hospital. The high number of COVID-19 cases, the majority of which were patients with more severe disease, confirms good to excellent patient management outcomes.
[1] Shahsavarinia K, Ghojazadeh M, Ghabousian A, Hatefnia F, Soleimanpour M, Soleimanpour H. An umbrella review of clinical efficacy and adverse cardiac events associated with hydroxychloroquine or chloroquine with or without azithromycin in patients with COVID-19. Anesth Pain Med. 2021; 11(4):e115827.
[2] Soleimanpour H, Sarbazi E, Esmaeili ED, Mehri A, Fam SG, Nikbakht HA, et al. Predictors of receiving COVID-19 vaccine among adult population in Iran: an observational study. BMC Public Health. 2023; 23(1):490.
[3] Bagi HM, Soleimanpour M, Abdollahi F, Soleimanpour H. Evaluation of clinical outcomes of patients with mild symptoms of coronavirus disease 2019 (COVID-19) discharged from the emergency department. PLoS One. 2021; 16(10):e0258697.
[4] Shahsavarinia K, Amiri P, Mousavi Z, Gilani N, Saadati M, Soleimanpour H. Prediction of PTSD related to COVID-19 in emergency staff based on the components of self-compassion and perceived social support. BMC Psychiatry. 2022; 22(1):368.
[5] Rezabakhsh A, Mojtahedi F, Tahsini Tekantapeh S, Mahmoodpoor A, Ala A, Soleimanpour H. Therapeutic impact of tocilizumab in the setting of severe COVID-19; an updated and comprehensive review on current evidence. Arch Acad Emerg Med. 2024; 12(1):e47.
[6] Kabiri N, Abbasi A, Pashazadeh F, Hajebrahimi S, Soleimanpour H. The impact of the COVID-19 pandemic on hospital admissions due to road traffic crashes; a systematic review and meta-analysis. Arch Acad Emerg Med. 2023; 12(1):e12.
[7] Balafar M, Mahmoodpoor A, Arjmandi H, Maddah Khelejani A, Soleimanpour H. High-dose vitamin C in the treatment of COVID-19 patients in intensive care unit; a letter to the editor. Arch Acad Emerg Med. 2024; 12(1):e41.
[8] Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-74.
[9] Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-23.
[10] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18):1708-20.
[11] Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020; 296(2):E15-E25.
[12] Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020; 296(2):E115-E117.
[13] Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020; 296(2):E32-E40.
[14] World Health Organization (WHO). WHO coronavirus (COVID-19) dashboard [Internet]. Available from: https://covid19.who.int/
[15] Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran: actions and problems. Infect Control Hosp Epidemiol. 2020; 41(6):754-5.
[16] Magunia H, Lederer S, Verbuecheln R, Gilot BJ, Koeppen M, Haeberle HA, et al. Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort. Crit Care. 2021; 25(1):295.
[17] Khan Chachar AZ, Asif M, Tanveer K, Rauf MK, Iqbal J, Khan K, et al. Clinical characteristics, comorbidities, and outcome of critically sick patients with COVID-19 pneumonia admitted in the intensive care unit of a tertiary care hospital in Lahore, Pakistan: a retrospective cohort study. Cureus. 2022; 14(5):e25286.
[18] Kumar R, Patel N, Kodan P, Aggarwal R, Dass C, Soni KD, et al. Clinical profile and outcome of critically ill COVID-19 patients with malignancy admitted in intensive care unit of a tertiary COVID center, India. Cureus. 2021; 13(7):e16553.
[19] Kaur M, Aggarwal R, Ganesh V, Kumar R, Patel N, Ayub A, et al. Clinical course and outcome of critically ill obese patients with COVID-19 admitted in intensive care unit of a single center: our experience and review. Indian J Crit Care Med. 2021; 25(12):1382-6.
[20] Estabraghnia Babaki H, Jarineshin H, Saljoughi F, Hassaniazad M, Rafati S, Sohrabipour S. Clinical features and outcomes of ICU patients confirmed with COVID-19 infection in Bandar Abbas, Iran: a single-centered retrospective study. Tanaffos. 2022; 21(4):455-65.
[21] Rigo-Bonnin R, Gumucio-Sanguino VD, Pérez-Fernández XL, Corral-Ansa L, Fuset-Cabanes M, Pons-Serra M, et al. Individual outcome prediction models for patients with COVID-19 based on their first day of admission to the intensive care unit. Clin Biochem. 2022; 100:13-21.
[22] Dongelmans DA, Termorshuizen F, Brinkman S, Bakhshi-Raiez F, Arbous MS, de Lange DW, et al. Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands. Ann Intensive Care. 2022; 12(1):5.
[23] Khalid I, Alshukairi AN, Khalid TJ, Imran M, Imran M, Akhtar MA, et al. Characteristics and outcome of tertiary care critically ill COVID-19 patients with multiple comorbidities admitted to the intensive care unit. Ann Thorac Med. 2022; 17(1):59-65.
[24] World Health Organization (WHO). Coronavirus disease (COVID-19) pandemic [Internet]. Available at: https://www.who.int/emergencies/disease/novel-coronavirus-2019
[25] Shaman J, Kohn M. Absolute humidity modulates influenza survival, transmission, and seasonality. Proc Natl Acad Sci U S A. 2009; 106(9):3243-8.
[26] Baker RE, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic. Science. 2020; 369(6501):315-9.
[27] Armstrong RA, Kane AD, Kursumovic E, Oglesby FC, Cook TM. Mortality in patients admitted to intensive care with COVID-19: an updated systematic review and meta-analysis of observational studies. Anaesthesia. 2021; 76(4):537-48.
[28] Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323(20):2098.
[29] Ranney ML, Griffeth V, Jha AK. Critical supply shortages - the need for ventilators and personal protective equipment during the COVID-19 pandemic. N Engl J Med. 2020; 382(18):e41.
[30] Maves RC, Downar J, Dichter JR, Hick JL, Devereaux A, Geiling JA, et al. Triage of scarce critical care resources in COVID-19: an implementation guide for regional allocation - an expert panel report of the Task Force for Mass Critical Care and the American College of Chest Physicians. Chest. 2020; 158(1):212-25.
[2] Soleimanpour H, Sarbazi E, Esmaeili ED, Mehri A, Fam SG, Nikbakht HA, et al. Predictors of receiving COVID-19 vaccine among adult population in Iran: an observational study. BMC Public Health. 2023; 23(1):490.
[3] Bagi HM, Soleimanpour M, Abdollahi F, Soleimanpour H. Evaluation of clinical outcomes of patients with mild symptoms of coronavirus disease 2019 (COVID-19) discharged from the emergency department. PLoS One. 2021; 16(10):e0258697.
[4] Shahsavarinia K, Amiri P, Mousavi Z, Gilani N, Saadati M, Soleimanpour H. Prediction of PTSD related to COVID-19 in emergency staff based on the components of self-compassion and perceived social support. BMC Psychiatry. 2022; 22(1):368.
[5] Rezabakhsh A, Mojtahedi F, Tahsini Tekantapeh S, Mahmoodpoor A, Ala A, Soleimanpour H. Therapeutic impact of tocilizumab in the setting of severe COVID-19; an updated and comprehensive review on current evidence. Arch Acad Emerg Med. 2024; 12(1):e47.
[6] Kabiri N, Abbasi A, Pashazadeh F, Hajebrahimi S, Soleimanpour H. The impact of the COVID-19 pandemic on hospital admissions due to road traffic crashes; a systematic review and meta-analysis. Arch Acad Emerg Med. 2023; 12(1):e12.
[7] Balafar M, Mahmoodpoor A, Arjmandi H, Maddah Khelejani A, Soleimanpour H. High-dose vitamin C in the treatment of COVID-19 patients in intensive care unit; a letter to the editor. Arch Acad Emerg Med. 2024; 12(1):e41.
[8] Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-74.
[9] Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-23.
[10] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18):1708-20.
[11] Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020; 296(2):E15-E25.
[12] Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020; 296(2):E115-E117.
[13] Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020; 296(2):E32-E40.
[14] World Health Organization (WHO). WHO coronavirus (COVID-19) dashboard [Internet]. Available from: https://covid19.who.int/
[15] Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran: actions and problems. Infect Control Hosp Epidemiol. 2020; 41(6):754-5.
[16] Magunia H, Lederer S, Verbuecheln R, Gilot BJ, Koeppen M, Haeberle HA, et al. Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort. Crit Care. 2021; 25(1):295.
[17] Khan Chachar AZ, Asif M, Tanveer K, Rauf MK, Iqbal J, Khan K, et al. Clinical characteristics, comorbidities, and outcome of critically sick patients with COVID-19 pneumonia admitted in the intensive care unit of a tertiary care hospital in Lahore, Pakistan: a retrospective cohort study. Cureus. 2022; 14(5):e25286.
[18] Kumar R, Patel N, Kodan P, Aggarwal R, Dass C, Soni KD, et al. Clinical profile and outcome of critically ill COVID-19 patients with malignancy admitted in intensive care unit of a tertiary COVID center, India. Cureus. 2021; 13(7):e16553.
[19] Kaur M, Aggarwal R, Ganesh V, Kumar R, Patel N, Ayub A, et al. Clinical course and outcome of critically ill obese patients with COVID-19 admitted in intensive care unit of a single center: our experience and review. Indian J Crit Care Med. 2021; 25(12):1382-6.
[20] Estabraghnia Babaki H, Jarineshin H, Saljoughi F, Hassaniazad M, Rafati S, Sohrabipour S. Clinical features and outcomes of ICU patients confirmed with COVID-19 infection in Bandar Abbas, Iran: a single-centered retrospective study. Tanaffos. 2022; 21(4):455-65.
[21] Rigo-Bonnin R, Gumucio-Sanguino VD, Pérez-Fernández XL, Corral-Ansa L, Fuset-Cabanes M, Pons-Serra M, et al. Individual outcome prediction models for patients with COVID-19 based on their first day of admission to the intensive care unit. Clin Biochem. 2022; 100:13-21.
[22] Dongelmans DA, Termorshuizen F, Brinkman S, Bakhshi-Raiez F, Arbous MS, de Lange DW, et al. Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands. Ann Intensive Care. 2022; 12(1):5.
[23] Khalid I, Alshukairi AN, Khalid TJ, Imran M, Imran M, Akhtar MA, et al. Characteristics and outcome of tertiary care critically ill COVID-19 patients with multiple comorbidities admitted to the intensive care unit. Ann Thorac Med. 2022; 17(1):59-65.
[24] World Health Organization (WHO). Coronavirus disease (COVID-19) pandemic [Internet]. Available at: https://www.who.int/emergencies/disease/novel-coronavirus-2019
[25] Shaman J, Kohn M. Absolute humidity modulates influenza survival, transmission, and seasonality. Proc Natl Acad Sci U S A. 2009; 106(9):3243-8.
[26] Baker RE, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic. Science. 2020; 369(6501):315-9.
[27] Armstrong RA, Kane AD, Kursumovic E, Oglesby FC, Cook TM. Mortality in patients admitted to intensive care with COVID-19: an updated systematic review and meta-analysis of observational studies. Anaesthesia. 2021; 76(4):537-48.
[28] Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323(20):2098.
[29] Ranney ML, Griffeth V, Jha AK. Critical supply shortages - the need for ventilators and personal protective equipment during the COVID-19 pandemic. N Engl J Med. 2020; 382(18):e41.
[30] Maves RC, Downar J, Dichter JR, Hick JL, Devereaux A, Geiling JA, et al. Triage of scarce critical care resources in COVID-19: an implementation guide for regional allocation - an expert panel report of the Task Force for Mass Critical Care and the American College of Chest Physicians. Chest. 2020; 158(1):212-25.
| Files | ||
| Issue | Article in Press |
|
| Section | Research Article(s) | |
| Keywords | ||
| COVID-19 Outcome Intensive Care Unit acute respiratory syndrome | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Mohammadzadeh Lame M, EJ Golzari S, Mahmoodpoor A, Taghizadeh Anhari A, Naderian S, Jafari N, Soleimanpour M, Mehdizadeh Esfanjani R, Faghieh Dinavari M, Soleimanpour H. Evaluation of Outcome and Performance of COVID-19 ICUs in Imam Reza General Hospital, Tabriz, Iran. Arch Anesth & Crit Care. 2026;.
